James Rucker is a Clinician Scientist Fellow funded by the UK National Institute for Health Research in mood disorders at The Institute of Psychiatry, Psychology & Neuroscience, King’s College London and Honorary Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust. Dr Rucker completed his medical degree at University College London (UK) in 2003 before training in psychiatry at the Maudsley, Bethlem and Springfield Hospitals in South London. He completed his PhD in the molecular biology of mood disorders at King’s College London in 2012 under Emeritus Professor Peter McGuffin. Dr Rucker specialises clinically and academically in mental health problems predominantly associated with mood, anxiety and trauma response symptoms and is particularly interested in novel drug treatments and drug catalysed forms of psychotherapy in the same. He leads the Psychedelic Trials Group at King’s College London, with Professor Allan Young. Clinically, he works at a specialist treatment centre for mood disorders at The Maudsley. He is also a Consultant Psychiatrist for Sapphire Medical Clinics, the first Medical Cannabis Clinic in the UK to be approved by the Care Quality Commission.